The Wall Street Journal Profiles NYSCF CEO and Co-Founder Susan L. Solomon

The Wall Street Journal profiled Susan L. Solomon, NYSCF CEO and Co-Founder. Part of the “Weekend Confidential” series, previously headlining Robert A.M. Stern, Tom Colicchio, and Cynthia Breazeal, the piece features NYSCF’s work towards preventing mitochondrial diseases, supporting Alzheimer’s clinical trials, and finding a cure for diabetes. Writer, Alexandra Wolfe, highlights Ms. Solomon’s rich career history in executive positions in law and business before advocating for cures. The article honors Ms. Solomon’s vision of a nonprofit to accelerate critical research and improve treatments. She saw stem cell research as a field that was not moving quickly enough to realize its potential. She wanted to create a pathway to conduct research unencumbered by government regulation and funding. Since her son’s diabetes diagnosis, Ms. Solomon had long served as a patient advocate. In 2005, she co-founded NYSCF. Ms. Solomon shares with The Wall Street Journal the importance and intricacies of stem cell research and how stem cells can help scientists finally find cures for diabetes and other diseases in humans, rather than animal models.

 

Read the article on The Wall Street Journal >>

Diseases & Conditions:

Diabetes, Stem Cell Biology

People mentioned: